Pharmaceutical Executive July 6, 2023
Francis Pollaro

Senior editor Fran Pollaro chats with Sharlene Jenner, vice president of engagement strategy, Abelson Taylor about the transformative impact and ethical considerations of AI in the pharmaceutical industry, emphasizing its potential in data analysis and marketing, while also highlighting the pioneering work of AI companies in advancing drug discovery.

Welcome to a riveting episode of the Pharm Exec podcast, where we dive headfirst into the transformative world of AI in healthcare with Sharlene Jenner, vice president of engagement strategy with the award-winning agency Abelson Taylor. This enlightening conversation traverses the advancements and potential risks of AI, the revolution it is stirring in pharmaceutical marketing, and its game-changing role in understanding complex protein structures. Amid the rapid innovation, we explore the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Govt Agencies, Regulations, Technology, Trends
What’s Next For AI In Healthcare
At CES 2025 Digital Hollywood Conference, AI Grabs The Spotlight
Move Over GenAI. Google Says Get Ready for GenWorld
Why “Living Intelligence” Is the Next Big Thing
Will AI revolutionize drug development? Researchers explain why it depends on how it's used

Share This Article